BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wendel S, Kutner JM, Machado R, Fontão-Wendel R, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Dal Ben M, Araujo D, Soares C, Camargo A, Kallás E, Durigon E, Reis LF, Rizzo LV. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Transfusion 2020;60:2938-51. [PMID: 32935877 DOI: 10.1111/trf.16065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Laterza R, Schirinzi A, Bruno R, Genco R, Contino R, Ostuni A, Di Serio F. SARS-CoV-2 antibodies: Comparison of three high-throughput immunoassays versus the neutralization test. Eur J Clin Invest 2021;51:e13573. [PMID: 33870493 DOI: 10.1111/eci.13573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Izak M, Gendelman V, Bransburg-Zabary S, Stoyanov E, Gat R, Cohen D, Chen J, Maor Y, Benov A, Lev B, Zimhony O, Shinar E. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel. Vox Sang 2021. [PMID: 34125976 DOI: 10.1111/vox.13162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 de Freitas Dutra V, Bonet-Bub C, Yokoyama APH, Achkar R, Machado RRG, Assunção M, Candelária G, Soares CP, Fachini RM, Fontão-Wendel R, Hamerschlak N, Reis LFL, Araujo DB, Nudelman V, Pinho JRR, Rizzo LV, Sakashita AM, Scuracchio P, Durigon EL, Wendel S, Kutner JM. Anti-A and SARS-CoV-2: an intriguing association. Vox Sang 2021;116:557-63. [PMID: 33650690 DOI: 10.1111/vox.13044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Aryal S, Pandit S, Pokhrel S, Chhusyabaga M, Bista P, Bhatt MP, Subedi DD, Rijal BP, Saki M. Anti-SARS-CoV-2 Antibody Screening in Healthcare Workers and Its Correlation with Clinical Presentation in Tertiary Care Hospital, Kathmandu, Nepal, from November 2020 to January 2021. Interdisciplinary Perspectives on Infectious Diseases 2022;2022:1-8. [DOI: 10.1155/2022/8515051] [Reference Citation Analysis]
5 Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N, Shinar E, Izak M, Gonzalez CA, Ferrari DM, Cini PV, Aditya RN, Sharma RR, Sachdev S, Hans R, Lamba DS, Nissen-Meyer LSH, Devine DV, Lee CK, Leung JN, Hung IFN, Tiberghien P, Gallian P, Morel P, Al Maamari K, Al-Hinai Z, Vrielink H, So-Osman C, De Angelis V, Berti P, Ostuni A, Marano G, Nevessignsky MT, El Ekiaby M, Daly J, Hoad V, Kim S, van den Berg K, Vermeulen M, Glatt TN, Schäfer R, Reik R, Gammon R, Lopez M, Estcourt L, MacLennan S, Roberts D, Louw V, Dunbar N. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Responses. Vox Sang 2021. [PMID: 34013981 DOI: 10.1111/vox.13114] [Reference Citation Analysis]
6 Zucherato VS, Evaristo M, Santos EV, Mello R, Donizetti Candido É, Araujo DB, de Oliveira DBL, Durigon EL, Giovanetti M, Alcantâra LCJ, Cilião-Alves DC, Haddad R, Covas DT, Kashima S, Slavov SN. SARS-CoV-2 serological cross-reactivity testing in Brazilian blood donors, October-December, 2019. J Infect 2022:S0163-4453(21)00660-5. [PMID: 34979220 DOI: 10.1016/j.jinf.2021.12.041] [Reference Citation Analysis]
7 Al-Riyami AZ, Burnouf T, Yazer M, Triulzi D, Kumaş LT, Sağdur L, Pelit NB, Bazin R, Hindawi SI, Badawi MA, Patidar GK, Pandey HC, Chaurasia R, Fachini RM, Scuracchio P, Wendel S, Ang AL, Ong KH, Young P, Ihalainen J, Vierikko A, Qiu Y, Yang R, Xu H, Rahimi-Levene N, Shinar E, Izak M, Gonzalez CA, Ferrari DM, Cini PV, Aditya RN, Sharma RR, Sachdev S, Hans R, Lamba DS, Nissen-Meyer LSH, Devine DV, Lee CK, Leung JN, Hung IFN, Tiberghien P, Gallian P, Morel P, Al Maamari K, Al-Hinai Z, Vrielink H, So-Osman C, De Angelis V, Berti P, Ostuni A, Marano G, Nevessignsky MT, El Ekiaby M, Daly J, Hoad V, Kim S, van den Berg K, Vermeulen M, Glatt TN, Schäfer R, Reik R, Gammon R, Lopez M, Estcourt L, MacLennan S, Roberts D, Louw V, Dunbar N; ISBT Convalescent Plasma Group. International Forum on the Collection and Use of COVID-19 Convalescent Plasma: Protocols, Challenges and Lessons Learned: Summary. Vox Sang 2021. [PMID: 34013968 DOI: 10.1111/vox.13113] [Reference Citation Analysis]
8 Yokoyama APH, Wendel S, Bonet-Bub C, Fachini RM, Dametto APF, Blumm F, Dutra VF, Candelaria GTP, Sakashita AM, Machado RRG, Fontão-Wendel R, Hamerschlak N, Achkar R, Assunção MSC, Scuracchio P, Nudelman V, Pastore L, Pinho JRR, Ben MD, Filho RK, Marra AR, Amano MT, Kallás EG, Helito AS, de Carvalho CRR, Araujo DB, Durigon EL, Camargo AA, Rizzo LV, Reis LFL, Kutner JM. COVID-19 convalescent plasma cohort study: Evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion 2021;61:2295-306. [PMID: 34173248 DOI: 10.1111/trf.16573] [Reference Citation Analysis]
9 Mendrone-Junior A, Dinardo CL, Ferreira SC, Nishya A, Salles NA, de Almeida Neto C, Hamasaki DT, Facincani T, de Oliveira Alves LB, Machado RRG, Araujo DB, Durigon EL, Rocha V, Sabino EC. Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing. Transfusion 2021;61:1181-90. [PMID: 33491194 DOI: 10.1111/trf.16268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
10 Sekine L, Arns B, Fabro BR, Cipolatt MM, Machado RRG, Durigon EL, Parolo E, Pellegrini JAS, Viana MV, Schwarz P, Lisboa TC, Dora JMS, Portich JP, Paz AA, Silla L, Balsan AM, Schirmer FD, Franz JPM, da-Silveira LM, Breunig RC, Petersen V, Sosnoski M, Mesquita NF, Volpato FCZ, Sganzerla D, Falavigna M, Rosa RG, Zavascki AP; PLACOVID Study Group. Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial. Eur Respir J 2021:2101471. [PMID: 34244316 DOI: 10.1183/13993003.01471-2021] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Wendel S, Kutner JM, Machado R, Fontão-Wendel R, Bub C, Fachini R, Yokoyama A, Candelaria G, Sakashita A, Achkar R, Hamerschlak N, Scuracchio P, Amaral M, Dal Ben M, Araujo D, Soares C, Camargo A, Kallás E, Durigon E, Reis LF, Rizzo LV. Screening for SARS-CoV-2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program. Transfusion 2020;60:2938-51. [PMID: 32935877 DOI: 10.1111/trf.16065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
12 Peng HT, Rhind SG, Beckett A. Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis. JMIR Public Health Surveill 2021;7:e25500. [PMID: 33825689 DOI: 10.2196/25500] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
13 Silva Jr ARD, Villas-boas LS, Tozetto-mendoza TR, Honorato L, Paula AD, Witkin SS, Mendes-correa MC. Generation of neutralizing antibodies against Omicron, Gamma and Delta SARS-CoV-2 variants following CoronaVac vaccination. Rev Inst Med trop S Paulo 2022;64:e19. [DOI: 10.1590/s1678-9946202264019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Andreata-santos R, Machado RRG, Alves RPDS, Sales NS, Soares CP, Rodrigues KB, Silva MO, Favaro MTDP, Rodrigues-jesus MJ, Yamamoto MM, Andrade JBD, Fock RA, Margarido PFR, Carvalho CRG, Boscardin SB, Durigon EL, Ferreira LCS. Validation of Serological Methods for COVID-19 and Retrospective Screening of Health Employees and Visitors to the São Paulo University Hospital, Brazil. Front Cell Infect Microbiol 2022;12:787411. [DOI: 10.3389/fcimb.2022.787411] [Reference Citation Analysis]
15 Burnouf T, Gathof B, Bloch EM, Bazin R, de Angelis V, Patidar GK, Rastvorceva RMG, Oreh A, Goel R, Rahimi-levene N, Hindawi S, Al-riyami AZ, So-osman C. Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins against SARS-CoV-2. Transfusion Medicine Reviews 2022. [DOI: 10.1016/j.tmrv.2022.06.001] [Reference Citation Analysis]
16 Schlickeiser S, Schwarz T, Steiner S, Wittke K, Al Besher N, Meyer O, Kalus U, Pruß A, Kurth F, Zoller T, Witzenrath M, Sander LE, Müller MA, Scheibenbogen C, Volk HD, Drosten C, Corman VM, Hanitsch LG. Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Front Immunol 2020;11:628971. [PMID: 33584731 DOI: 10.3389/fimmu.2020.628971] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
17 Gupta D, Ahmed F, Tandel D, Parthasarathy H, Vedagiri D, Sah V, Krishna Mohan B, Khan RA, Kondiparthi C, Savari P, Jain S, Reddy S, Kumar JM, Khan N, Harshan KH. Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108981] [Reference Citation Analysis]
18 Karaca A, Guncikan MN, Sozmen NN, Karadag GG, Yilmaz M, Kinik K, Yilmaz FM. Longitudinal SARS-CoV-2 Seroconversion Course and Antibody Levels by Blood Groups in Convalescent Plasma Donors in Turkey. Medeni Med J 2021;36:185-92. [PMID: 34915675 DOI: 10.5222/MMJ.2021.00921] [Reference Citation Analysis]
19 Lopes AGD, Celestino CSH, Barros TTA, Fevereiro AG, Gejer DH, Oliveira FMF, Brasil JM, Bossolan RM, Pinto GCC, Santos ACEZ, Divan LA, Alves IAB, Oliveira DBL, Machado RRG, Thomazelli LM, Hiyane MI, Brelaz-Abreu L, Bragança-Jardim E, Heinen LBS, Barrientos ACM, Mau LB, Camara NOS, Bueno DF, Amano MT. Case Report: A Severe SARS-CoV-2 Infection in a Teenager With Angelman Syndrome. Front Med (Lausanne) 2021;8:629112. [PMID: 33777976 DOI: 10.3389/fmed.2021.629112] [Reference Citation Analysis]
20 De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi DM Jr, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA Jr, Pontelli MC, Gomes R, Miranda CH, Martins MA, Covas DT, Arruda E, Fonseca BAL, Calado RT. High-Dose Convalescent Plasma for Treatment of Severe COVID-19. Emerg Infect Dis 2022;28. [PMID: 35081022 DOI: 10.3201/eid2803.212299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
21 Sekiya EJ, Bellesso M, Alves A. CHALLENGES IN THE PRODUCTION OF COVID19 CONVALESCENT PLASMA - ANALYSIS OF DONOR RECRUITMENT. Hematol Transfus Cell Ther 2021. [PMID: 33817558 DOI: 10.1016/j.htct.2021.02.001] [Reference Citation Analysis]
22 Wendel S, Fachini R, Fontão-Wendel RCL, Mello R, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): How useful could they be? Transfusion 2021. [PMID: 34674284 DOI: 10.1111/trf.16714] [Reference Citation Analysis]
23 Wendel S, Fontão-Wendel R, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado R, Araujo D, Soares C, Durigon E. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections. Transfusion 2021;61:1447-60. [PMID: 33604884 DOI: 10.1111/trf.16323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Medeiros GX, Sasahara GL, Magawa JY, Nunes JPS, Bruno FR, Kuramoto AC, Almeida RR, Ferreira MA, Scagion GP, Candido ÉD, Leal FB, Oliveira DBL, Durigon EL, Silva RCV Jr, Rosa DS, Boscardin SB, Coelho V, Kalil J, Santos KS, Cunha-Neto E. Reduced T Cell and Antibody Responses to Inactivated Coronavirus Vaccine Among Individuals Above 55 Years Old. Front Immunol 2022;13:812126. [PMID: 35300337 DOI: 10.3389/fimmu.2022.812126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Cimolai N. Passive Immunity Should and Will Work for COVID-19 for Some Patients. Clin Hematol Int 2021;3:47-68. [PMID: 34595467 DOI: 10.2991/chi.k.210328.001] [Reference Citation Analysis]
26 Wendel S, Land K, Devine DV, Daly J, Bazin R, Tiberghien P, Lee CK, Arora S, Patidar GK, Khillan K, Smid WM, Vrielink H, Oreh A, Al-Riyami AZ, Hindawi S, Vermeulen M, Louw V, Burnouf T, Bloch EM, Goel R, Townsend M, So-Osman C. Lessons learned in the collection of convalescent plasma during the COVID-19 pandemic. Vox Sang 2021. [PMID: 33772791 DOI: 10.1111/vox.13096] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Focosi D, Franchini M. Clinical predictors of SARS-CoV-2 neutralizing antibody titers in COVID-19 convalescents: Implications for convalescent plasma donor recruitment. Eur J Haematol 2021;107:24-8. [PMID: 33780551 DOI: 10.1111/ejh.13630] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
28 Körper S, Jahrsdörfer B, Corman VM, Pilch J, Wuchter P, Blasczyk R, Müller R, Tonn T, Bakchoul T, Schäfer R, Juhl D, Schwarz T, Gödecke N, Burkhardt T, Schmidt M, Appl T, Eichler H, Klüter H, Drosten C, Seifried E, Schrezenmeier H. Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies. Transfus Med Hemother 2021;48:137-47. [PMID: 34177417 DOI: 10.1159/000515610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Benites BD, Costa-Lima C, Pinto FBR, da Costa VA, Duarte ADSS, Zangirolami AB, Amaro EC, Granja F, Proenca-Modena JL, Saad STO, Addas-Carvalho M. Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements. Transfus Apher Sci 2022;:103513. [PMID: 35871137 DOI: 10.1016/j.transci.2022.103513] [Reference Citation Analysis]
30 do Couto AC, Kmetiuk LB, Delai RR, Brandão APD, Monteiro CO, da Silva LHA, Soares C, Banari AC, Bach RVW, Pettan-Brewer C, Dos Santos AP, Guimarães AMS, Oliveira DBL, Durigon EL, Biondo AW. High SARS-CoV-2 seroprevalence in persons experiencing homelessness and shelter workers from a day-shelter in São Paulo, Brazil. PLoS Negl Trop Dis 2021;15:e0009754. [PMID: 34665803 DOI: 10.1371/journal.pntd.0009754] [Reference Citation Analysis]